openPR Logo
Press release

Anemia Drugs Market Increasing Awareness of Anemia & Anticipated To Create New Opportunities For Market During 2017-2025

02-08-2019 06:58 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Anemia Drugs Market

Anemia Drugs Market Increasing Awareness of Anemia &

MarketResearchReports.Biz is providing you Retail Market Research report of "Anemia Drugs Market - Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 - 2025".

Anemia is a common cause of qualitative or quantitative deficiency of hemoglobin. Hemoglobin is an iron rich protein that caries the oxygen from lungs to the other parts of body tissue. The hemoglobin deficiency is generally associated with the decrease in the number of red blood cells and hematocrit. Anemia causes low transfer of oxygen to the rest of the body. Anemia is easily preventable and treated however, there are mild or vague symptoms for detection of anemia due to which anemia mostly goes undetectable. Commonly, the symptoms such as weakness or fatigue due to exercise, malaise and sometimes poor concentration are observed in patients with anemia.

Get Sample Copy Of This Report @

In addition, as the anemia progresses patients suffer from shortness of breath due to exertion, increase in cardiac output leading to palpitations, sweeting and heart failure. Anemia is commonly found in patients with nutrition deficiency (poor iron or vitamin diet), chronic diseases (such as cancer, kidney diseases, diabetes, etc.), chronic infections (such as HIV, tuberculosis, etc.) and high blood loss (due to injury, menstrual bleeding, surgery etc.). Anemia is hereditary or acquired disorder that affects the hemoglobin synthesis such as sickle cell anemia and thalassemia. Furthermore, bone marrow and stem cell reduction may result into anemia. More than 400 types of anemia are diagnosed which vary according to the causes and symptoms.

The high rate of nutrition deficiency is the major driving factor of anemia drugs market, globally. According to WHO estimates, around 50% of cases of anemia are reported due to iron deficiency. The increase in prevalence of chronic diseases and disorders and growing baby blooming population are escalating the anemia drugs market. The increase in anemia due to lack of proper nutritional diet in undeveloped countries are increasing the anemia drugs market. According to the World Bank, anemia is the 8th leading cause of disease among the women and young girls. The government initiatives in improving the healthcare facilities in developing countries is estimated to drive the market growth. However, adverse effects associated with the medications of anemia drugs is anticipated to hinder the market growth. For instance, patients with diabetes taking iron for anemia, may increase the risk of heart diseases. The ongoing research and development associated with the anemia drugs and increasing awareness of anemia in developing and undeveloped countries is anticipated to create new opportunities for the market during the forecast period.

Request For TOC @

The global anemia drugs market is segmented on basis of anemia type, drugs, distribution channel and geography

Based on anemia type, the global anemia drugs market is segmented into the following:

Microcytic (Low MCV)
Iron deficiency
Others (Sideroblastic anemia, lead toxicity,etc)
Normocytic (Normal MCV)
High Reticulocyte Count (hereditary, blood loss, hemangioma, sickle cell anemia,etc)
Low Reticulocyte Count (Diamond blackfan syndrome, anemia due to renal diseases and chronic diseases, etc)
Macrocytic (High MCV)
Vitamin deficiency
Based on drugs, the global anemia drugs market is segmented into the following:

Dietary supplements
Iron supplements
Vitamin supplements
Folic Acid
Vitamin C
Vitamin B12
Hormones (Erythropoietin )
Chelation therapy (lead poisoning)
Based on distribution channel, the global anemia drugs market is segmented into the following:

Hospitals Pharmacy
Online Pharmacy
The rise in intake of NSAIDs due to hectic lifestyle such as aspirin and ibuprofen leading to ulcers and gastritis that causes anemia is significantly increasing the market growth, globally. The increasing awareness of anemia drugs in developing countries is anticipated to increase the market growth. Furthermore, the increase in research and development associated with the anemia drugs is expected to fuel the anemia drugs market growth during the forecast period. For instance, in November 2017, FDA approved Auryxia® (ferric citrate) Tablets as a Treatment for People with Iron Deficiency Anemia and Chronic Kidney Disease, Not on Dialysis.

North America holds a significant market share of the Anemia Drugs market owing to the well-established increase in lifestyle diseases and chronic diseases such as diabetes, cancer and others. Furthermore, Asia Pacific and Middle East & Africa regions are anticipated to show considerable growth rate owing to increase in government investment in healthcare sector and increasing awareness of the anemia in the region.

Some of the key players present in global anemia drugs market are Amgen Inc., Keryx Biopharmaceuticals, Inc., GlaxoSmithKline plc, Pfizer Inc., Emmaus Medical Inc., Allergan Inc., Meda Cuonsumer Healthcare Inc., F. Hoffmann La Roche AG, Abbvie Inc, Johnson and Johnson, and others. The companies are focusing on research and development of new drugs to increase their market share in the anemia drugs market.

The report covers exhaustive analysis on:

Anemia Drugs Market Segments
Anemia Drugs Market Dynamics
Historical Actual Market Size, 2012 - 2016
Anemia Drugs Market Size & Forecast 2017 to 2025
Anemia Drugs Market Current Trends/Issues/Challenges
Competition & Companies involved
Anemia Drugs Market Drivers and Restraints
Regional analysis includes

North America
Latin America
Asia Pacific
Middle East & Africa
Report Highlights:

Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size
Recent industry trends
Key Competition landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance
MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.

The report provides the following information:

Tailwinds and headwinds molding the market’s trajectory
Market segments based on products, technology, and applications
Prospects of each segment
Overall current and possible future size of the market
Growth pace of the market
Competitive landscape and key players’ strategies
The main aim of the report is to:

Enable key stakeholder’s in the market bet right on it
Understand the opportunities and pitfalls awaiting them
Assess the overall growth scope in the near term
Strategize effectively with respect to production and distribution
MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.

Pre Book Report @

About Us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact Us

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anemia Drugs Market Increasing Awareness of Anemia & Anticipated To Create New Opportunities For Market During 2017-2025 here

News-ID: 1571110 • Views:

More Releases from Anemia Drugs Market

Global Anemia Drugs Market Expected To Be Bolstered By Release Of Key Pipeline D …
The latest report, titled “Global Anemia Drugs Market (Iron Deficiency, Sickle Cell, CKD, Aplastic Anemia): Analysis By Region, By Country (2016-2021) (By Type - Iron Deficiency Anemia, Chronic Kidney Disease Related Anemia, Sickle Cell Anemia, Aplastic Anemia: By Region-North America, Europe, APAC, Latin America, MEA:By Country - USA, Canada, UK, Germany, India, Brazil, South Africa),” is a highly detailed dossier on the measures taken by healthcare organizations for the treatment

More Releases for Vitamin

Global Vitamins Market, By Source (Plant, Animal), Product Type (Vitamin A, Vita …
Vitamins are organic compounds that are essential for every organism in a small amount for proper growth and development of the body. Lack of these vitamins may led to various vitamins deficiency diseases and disorders such as night blindness, xerophthalmia and keratomalacia. Growing consumer awareness for various vitamins deficiency diseases across the world in turn is expected to boost growth of the global market for vitamins. These vitamins can be
Global Vitamin Market 2019- By Product Type (Vitamin A,Vitamin B3,Vitamin B5,Vit …
"Global Vitamin Market - Volume and Value Analysis By Product Type (Vitamin A,Vitamin B3,Vitamin B5,Vitamin D3,Vitamin E,Vitamin C), By End User, By Region, By Country: Opportunities and Forecast (2019-2025) - By Region (N. America, ROW,Europe, APAC ), By Country (USA, Canada, Mexico, Rest of Europe, China, India, Japan,Rest of North America, Germany, France, Italy, Spain,  South Korea, Rest of Asia)" Key Players Dominating the Global Vitamin Market  DSM, Lonza, CSPC Pharmaceutical Group,
Vitamin D3 Market Insights by Vitamin D3 Oil, Vitamin D3 Powder and Vitamin D3 C …
Latest Report on Vitamin D3 is announced by ReportsWeb and is available in its database. In this report, Vitamin D3 market is segmented on the basis of application, type, end use and regions. In addition, the report presents detailed information regarding major revenue generating regions of Vitamin D3 market. Meaning of Vitamin D3: Vitamin D3, also known as cholecalciferol, is the chemical 9,10-seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol. Vitamin D3 occurs in and is isolated from fish
Increasing Demand For Vitamin Added Foods & Cosmetics Boosted Global Vitamin Ing …
SAN FRANCISCO, Oct. 31, 2017 Global Vitamin Ingredients Market size was valued at $5,843 Million in 2016 and expected to reach $8,573 Million by 2024; growing at a CAGR of 4.9% from 2016 to 2024. In geographical segments, Asia Pacific and Europe are anticipated to grow at a fastest CAGR of 5.4% and 5.3%, respectively, over the forecast period 2016 – 2024. To browse the complete report, visit at
Vitamin D Ingredients Development Market: Vitamin D3 to Outrank Vitamin D2 as th …
"Vitamin D Ingredients Market: Vitamin D3 to Outrank Vitamin D2 as the Most Attractive Segment in Value and Volume Terms Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Recording the highest CAGR both in terms of value and volume, the Vitamin D3 segment is the undoubted leader in the product type segment The Vitamin
Vitamin Power's Juniper Berry Is Discontinued At the Vitamin Mineral Shop
Vitamin Power has discontinued this natural herbal product, Juniper Berry, and thus it is now discontinued at the Vitamin Mineral Shop. Clinton Township, Michigan -- Established in 1975, Vitamin Power is an exclusive line of nutritional healthcare products. The discontinuance of Juniper Berry (product id 664R) is a reluctant reduction is the size of the product line. Vitamin Power will continue to distribute its other products in the same manner